Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 142

Similar articles for PubMed (Select 8673089)

1.

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes.

Thorlacius S, Olafsdottir G, Tryggvadottir L, Neuhausen S, Jonasson JG, Tavtigian SV, Tulinius H, Ogmundsdottir HM, Eyfjörd JE.

Nat Genet. 1996 May;13(1):117-9.

PMID:
8673089
2.

Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype.

Gudmundsson J, Johannesdottir G, Arason A, Bergthorsson JT, Ingvarsson S, Egilsson V, Barkardottir RB.

Am J Hum Genet. 1996 Apr;58(4):749-56.

4.

BRCA2 mutation in Icelandic prostate cancer patients.

Sigurdsson S, Thorlacius S, Tomasson J, Tryggvadottir L, Benediktsdottir K, Eyfjörd JE, Jonsson E.

J Mol Med (Berl). 1997 Oct;75(10):758-61.

PMID:
9383000
5.

Study of a single BRCA2 mutation with high carrier frequency in a small population.

Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, Tryggvadottir L, Tulinius H, Eyfjörd JE.

Am J Hum Genet. 1997 May;60(5):1079-84.

6.

Confirmation of susceptibility locus on chromosome 13 in Australian breast cancer families.

Grimmond SM, Palmer JM, Walters MK, Scott C, Nancarrow DJ, Teh BT, Elmes C, Pyke C, Khoo SK, Bennett I, Wetzig N, Hayward NK.

Hum Genet. 1996 Jul;98(1):80-5.

PMID:
8682513
7.

A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals.

Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK.

Cancer Res. 1996 Aug 1;56(15):3409-14.

8.

BRCA2 germline mutations in male breast cancer cases and breast cancer families.

Couch FJ, Farid LM, DeShano ML, Tavtigian SV, Calzone K, Campeau L, Peng Y, Bogden B, Chen Q, Neuhausen S, Shattuck-Eidens D, Godwin AK, Daly M, Radford DM, Sedlacek S, Rommens J, Simard J, Garber J, Merajver S, Weber BL.

Nat Genet. 1996 May;13(1):123-5.

PMID:
8673091
9.

A low proportion of BRCA2 mutations in Finnish breast cancer families.

Vehmanen P, Friedman LS, Eerola H, Sarantaus L, Pyrhönen S, Ponder BA, Muhonen T, Nevanlinna H.

Am J Hum Genet. 1997 May;60(5):1050-8.

10.

BRCA2 germ-line mutations in Spanish male breast cancer patients.

Díez O, Cortés J, Domènech M, Pericay C, Brunet J, Alonso C, Baiget M.

Ann Oncol. 2000 Jan;11(1):81-4.

11.

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA, Goldgar D.

Am J Hum Genet. 1998 Jun;62(6):1381-8.

12.

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families.

Tonin PN, Mes-Masson AM, Futreal PA, Morgan K, Mahon M, Foulkes WD, Cole DE, Provencher D, Ghadirian P, Narod SA.

Am J Hum Genet. 1998 Nov;63(5):1341-51.

13.

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds.

Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE.

Nat Genet. 1996 Mar;12(3):333-7.

PMID:
8589730
14.

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families.

Phelan CM, Lancaster JM, Tonin P, Gumbs C, Cochran C, Carter R, Ghadirian P, Perret C, Moslehi R, Dion F, Faucher MC, Dole K, Karimi S, Foulkes W, Lounis H, Warner E, Goss P, Anderson D, Larsson C, Narod SA, Futreal PA.

Nat Genet. 1996 May;13(1):120-2. Erratum in: Nat Genet 1996 Jul;13(3):374.

PMID:
8673090
15.

Molecular analysis of the BRCA2 gene in 16 breast/ovarian cancer Spanish families.

Osorio A, Robledo M, Martínez B, Cebrián A, San Román JM, Albertos J, Lobo F, Benítez J.

Clin Genet. 1998 Aug;54(2):142-7.

PMID:
9761393
16.

Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families.

Barkardottir RB, Sarantaus L, Arason A, Vehmanen P, Bendahl PO, Kainu T, Syrjäkoski K, Krahe R, Huusko P, Pyrhönen S, Holli K, Kallioniemi OP, Egilsson V, Kere J, Nevanlinna H.

Eur J Hum Genet. 2001 Oct;9(10):773-9.

17.

A large multisite cancer family is linked to BRCA2.

Tonin P, Ghadirian P, Phelan C, Lenoir GM, Lynch HT, Letendre F, Belanger D, Monté M, Narod SA.

J Med Genet. 1995 Dec;32(12):982-4.

18.
19.

Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

Håkansson S, Johannsson O, Johansson U, Sellberg G, Loman N, Gerdes AM, Holmberg E, Dahl N, Pandis N, Kristoffersson U, Olsson H, Borg A.

Am J Hum Genet. 1997 May;60(5):1068-78.

20.

Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families.

Ikeda N, Miyoshi Y, Yoneda K, Shiba E, Sekihara Y, Kinoshita M, Noguchi S.

Int J Cancer. 2001 Jan 1;91(1):83-8.

PMID:
11149425
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk